(PhysOrg.com) -- A new barcode chip developed by a multi-institutional team of investigators promises to revolutionize diagnostic medical testing. In less than 10 minutes and using just a pinprick’s worth of blood, the ...
Bio & Medicine
Dec 23, 2008
0
0
(Phys.org) —Herceptin and camptothecin are both powerful anticancer agents with key characteristics that limit their effectiveness in treating cancer. Patients treated with Herceptin, a monoclonal antibody that targets ...
Bio & Medicine
Jul 15, 2013
0
0
(Phys.org) —Activating the body's immune system to attack cancer and prevent it from recurring is one of the Holy Grails of cancer research because of its ability to specifically target cancer and to search almost anywhere ...
Bio & Medicine
Jul 15, 2013
0
0
(Phys.org) —In recent years, cancer researchers have been developing agents that destroy the blood vessels surrounding tumors with the goal of starving tumors to death. Some of these agents, such as tumor necrosis factor-alpha ...
Bio & Medicine
Jul 15, 2013
0
0
(Phys.org)—While most nanoparticles under development as drug delivery vehicles are spheres, a growing body of research suggests that cylindrical nanoparticles would perform even better at the twin goal of surviving in ...
Bio & Medicine
Oct 19, 2012
0
0
(Phys.org)—Since the advent of cancer nanotechnology, researchers have sought to use magnetic fields to increase the concentration of drug-loaded iron oxide nanoparticles that reach a tumor. However, magnetic fields drop ...
Bio & Medicine
Oct 19, 2012
0
0
Over the past six years, the National Cancer Institute’s (NCI) Nanotechnology Characterization Laboratory (NCL), a key component of the NCI’s Alliance for Nanotechnology in Cancer, has characterized more than 250 ...
Bio & Medicine
Aug 17, 2012
0
0
One of the challenges in treating cancer, whether using nanotechnology or not, is that tumors can often be inaccessible to the therapies designed to kill them. Mostafa El-Sayed, of the Georgia Institute of Technology, and ...
Bio & Medicine
Aug 17, 2012
3
0
In a nanotechnology two-for-one, researchers at the Johns Hopkins University Center of Cancer Nanotechnology Excellence (Hopkins CCNE) have created a polymer nanoparticle that overcomes tumor resistance to the common anticancer ...
Bio & Medicine
Aug 17, 2012
0
0
(Phys.org) -- Researchers at Johns Hopkins University (JHU) have created biodegradable, ultra tiny, nanosized particles that can easily slip through the body's sticky and viscous mucus secretions to deliver a sustained-release ...
Bio & Medicine
Jul 5, 2012
0
0
